Effectiveness and acceptability of progestogens in combined oral contraceptives – a systematic review
暂无分享,去创建一个
[1] R. Edgren,et al. Totally synthetic (±)-13-Alkyl-3-hydroxy and methoxy-gona-1,3,5(10)-trien-17-ones and related compounds , 1963, Experientia.
[2] C. Gerlinger,et al. Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 μg ethinylestradiol/100 μg levonorgestrel and 20 μg ethinylestradiol/500 μg norethisterone , 2001 .
[3] J. Foidart,et al. A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel. , 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[4] J. Foidart,et al. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone , 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[5] D. Mishell,et al. Progestins and Antiprogestins in Clinical Practice , 1999 .
[6] C. Gerlinger,et al. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study. , 1999, Contraception.
[7] I. Thorneycroft. Cycle control with oral contraceptives: A review of the literature. , 1999, American journal of obstetrics and gynecology.
[8] A. Di Lieto,et al. Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 μg ethinyl estradiol combined with 150 μg desogestrel or 75 μg gestodene , 1999 .
[9] Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 microg/ ethinylestradiol 15 microg and a 21-day regimen of desogestrel 150 microg/ethinylestradiol 20 microg. , 1999, European journal of contraception & reproductive health care.
[10] D. Serfaty,et al. A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene. , 1998, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[11] M. Rosenberg,et al. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. , 1998, American journal of obstetrics and gynecology.
[12] L. Bahamondes,et al. Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene. , 1998, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[13] W. Rossmanith,et al. [Comparative study on ovarian activity cycle stability and tolerance during administration of two low-dose oral contraceptives] , 1997 .
[14] W. Ledger,et al. A triphasic oral contraceptive pill, CTR-05: clinical efficacy and safety. , 1996, European journal of contraception & reproductive health care.
[15] S. Koetsawang,et al. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women. , 1995, Contraception.
[16] D. Shoupe. Multicenter Randomized Comparative Trial of Two Low‐Dose Triphasic Combined Oral Contraceptives Containing Desogestrel or Norethindrone , 1994, Obstetrics and Gynecology.
[17] Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl estradiol and desogestrel/ethinyl estradiol. Latin American Oral Contraceptive Study Group. , 1994, Contraception.
[18] C. Nappi,et al. Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: gestodene/ethinylestradiol and norgestimate/ethinylestradiol. , 1993, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[19] Ann E. Taylor. A Clinical Guide for Contraception , 1993 .
[20] F. Weber-Diehl,et al. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial. , 1993, Contraception.
[21] R. Mukherjee,et al. A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial. , 1993, Contraception.
[22] A. Decherney,et al. EVALUATION OF A NEW GENERATION OF ORAL CONTRACEPTIVES , 1993, Obstetrics and gynecology.
[23] P. Hillard. Oral contraception noncompliance: The extent of the problem , 1992, Advances in contraception : the official journal of the Society for the Advancement of Contraception.
[24] R. Percival-Smith,et al. Cycle control on low-dose oral contraceptives: a comparative trial. , 1990, Contraception.
[25] Reiter Sl,et al. Initial selection of oral contraceptives. , 1990 .
[26] N. Loudon,et al. A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30. , 1990, European journal of obstetrics, gynecology, and reproductive biology.
[27] L. Baer,et al. Initial selection of oral contraceptives. , 1990, Journal of reproductive medicine.
[28] W. Droegemueller,et al. Triphasic Randomized Clinical Trial: comparative frequency of intermenstrual bleeding. , 1989, American journal of obstetrics and gynecology.
[29] T. Osteria,et al. A comparative analysis of three different dose combinations of oral contraceptives. , 1989, Contraception.
[30] M. Kohlmeier,et al. Clinical and metabolic effects of gestodene and levonorgestrel. , 1987, International journal of fertility.
[31] N. Kase. Hormonal Contraception , 1970, The Yale Journal of Biology and Medicine.
[32] J. Siddall,et al. Totally synthetic plus or minus-13-alkyl-3-hydroxy and methoxy-gona-135 (10)-trien-17-ones and related compounds. , 1963 .